查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
止血帶全球市場 2023-2030
市場調查報告書
商品編碼
1217638

止血帶全球市場 2023-2030

Global Tourniquet Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

止血帶的全球市場規模預計到 2021 年將達到 3.9085 億美元，到 2029 年將達到 6.7821 億美元，在預測期內（2022-2029 年）以 7.9% 的複合年增長率增長。據說

使用止血帶是骨科和整形外科中常見的做法。 最大限度阻斷血流，創造無血手術野，抑制圍手術期出血的加壓裝置。 它還用於靜脈局部麻醉（啤酒阻滯）以抑制局部麻醉劑向中心擴散。

市場動態

在預測期內，骨科和整形外科手術數量的增加、交通事故傷害的增加等正在推動止血帶市場的增長。

止血帶在世界各地的肢體手術中得到了常規和安全的使用。 因此，骨科和整形手術的增加將推動全球止血帶市場的增長。 例如，根據歐盟2020年統計數據，2020年德國每10萬人約有294次膝關節置換，芬蘭、奧地利、荷蘭（2019年數據），丹麥每10萬人約有250至269次膝關節置換，其中有成為歐盟成員國中最常見的 此外，除馬耳他外，全膝關節置換術不如全髖關節置換術常見。 例如，到 2020 年，芬蘭和德國每 10 萬人口中將有超過 200 例全膝關節置換術。

此外，根據美國關節置換登記處2021，2021年將有超過1150家提供數據的機構進行超過240萬例髖關節和膝關節手術，手術總數較2020年增加18.3 %。 同樣，根據美國整形外科學院的數據，2020年將有大約1560萬例整容手術，其中包括230萬例整容手術和1320萬例微創整容手術，以及大約680萬例重建手術。據說已經完成了. 此外，越來越多的交通事故也促進了全球止血帶市場的增長。 例如，據世界衛生組織統計，每年約有130萬人死於道路突發事件。 大約有 20 至 5000 萬人遭受非致命傷害。 此外，疾病預防控制中心提供了 2020 年需要手術的非致命傷害的統計數據，大約有 2,885,545 例門診病例。 從以上數據來看，全球越來越多的骨科手術、整形手術和道路交通事故正在推動全球止血帶市場的增長。

止血帶損傷的發生抑制了全球止血帶市場的增長。

然而，止血帶在手術中的隱患在於，它威脅到臨床皮膚、肌肉、血管、結締組織和神經的損傷，因為麻木、麻痺和癱瘓伴有肌肉萎縮。 其中，缺氧和酸中毒主要引起組織缺血和肌肉損傷。 此外，止血帶釋放後灌注會導致生理性高血壓、體溫過低和氧應激，從而導致有毒代謝物再灌注到體循環中。 與使用此類止血帶相關的並發症在預測期內限制了全球市場的增長。

COVID-19 的影響

在 COVID-19 流行期間，對社交和社交聚會的限制減少了道路交通傷亡、運動損傷和其他需要手術干預的醫療狀況，導致全球市場增長放緩。 例如，根據國際美容整形外科學會的數據，整形手術在大流行期間有所下降。 大約 10.9%，大約 78% 的外科醫生經歷了臨時診所關閉。 此外，根據國家公共衛生研究所的數據，在大流行的第一年，骨科手術減少了約 23%。 其中，膝關節置換術的影響最大。 髖關節置換手術減少了約 64%，膝關節韌帶重建手術減少了約 41%、44%，對止血帶的需求也降低了。 這些統計數據表明，止血帶市場已受到 COVID-19 大流行的負面影響。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 骨科和整形外科手術人數增加
      • 交通事故增加
    • 約束因素
      • 止血帶造成的傷害
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章（按組件）

  • 止血帶裝置
  • 止血帶袖口
    • 氣動止血帶袖口
    • 非氣動止血帶袖口

第 8 章應用

  • 上肢手術
  • 下肢手術
  • 其他

第 9 章最終用戶

  • 醫院和診所
  • 門診手術中心
  • 骨科診所

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準

第12章公司簡介

  • 捷邁邦美
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Stryker
  • ATMOS MedizinTechnik GmbH & Co. KG
  • VBM
  • DDM
  • Anetic Aid
  • HPM
  • Huifeng Medical
  • DS MAREF
  • Bohus Medical

第13章 DataM

簡介目錄
Product Code: DMMD2821

Market Overview

The global tourniquet market size was valued at US$ 390.85 million in 2021 and is estimated to reach US$ 678.21 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

Tourniquet use is a familiar approach in orthopedic and plastic surgeries. They are compressive instruments that block blood flow to the extremes to produce a bloodless surgical field and reduce perioperative blood loss. They are also employed for intravenous regional anesthesia (Bier's block) to control the central spread of local anesthetics.

Market Dynamics

The growing number of orthopedic surgeries, plastic surgeries and the increasing incidents of road accident trauma drive the tourniquet Market growth during the forecast period.

Tourniquets are regularly and safely utilized in extremities surgeries throughout the globe. Thus, the increasing number of orthopedic and plastic surgeries boosts global tourniquet market growth. For instance, according to the European Union 2020 statistics, hip replacements were performed about 294 times per 100 000 residents in Germany in 2020 and between 250 and 269 times per 100 000 inhabitants in Finland, Austria, and the Netherlands (2019 data) and Denmark; these were the most elevated commonnesses among the EU Member States for which data are known, knee replacements varied more between the EU Member States than did hip replacements. Furthermore, except for Malta, total knee replacements were less common than hip replacements. For instance, in 2020, more than 200 knee replacements per 100 000 inhabitants were performed in Finland and Germany.

In addition, according to the American Joint Replacement Registry 2021, over 2.4 million hip and knee surgeries from over 1150 institutions that presented data took place in 2021, representing an 18.3% upsurge in total procedural volume compared with that in 2020. Likewise, according to the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures comprised 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures, and about 6.8 million reconstructive procedures were performed in 2020. Besides, the increasing number of road accidents contributes to the growth of the global tourniquet Market. For example, according to statistics from the world health organization, roughly 1.3 million people die yearly from road casualty emergencies. Almost 20-50 million individuals suffer from non-fatal injuries. Moreover, the CDC has supplied statistics of non-fatal injuries needing surgery in 2020, with approximately 2,885,545 ambulatory cases. From the data mentioned above, the rising number of orthopedic surgeries, plastic surgeries and incidents of road accidents worldwide is pushing the global tourniquet market growth.

The incidences of tourniquet injuries will restrain the global tourniquet market growth.

However, the implication of a tourniquet in surgery is the threat of clinical skin, muscle, blood vessels, connective tissue, and nerve damage because of numbness, paresis, or paralysis with muscle atrophy. Among these, hypoxia and acidosis primarily induce tissue ischemia and muscle damage. Furthermore, after releasing the tourniquet, perfusion leads to a physiological elevation in blood pressure, lowered body temperature, and oxygen stress, which is connected to the reentry toxic metabolites back into the systemic circulation. Such complications associated with tourniquet use are restraining the global market growth in the forecast period.

COVID-19 Impact.

During the COVID-19 pandemic, the constraint on socializing and social assemblages lessened the numeral of road traffic casualties, sports harms, and other medical ailments demanding surgical intervention, forcing a decline in the market growth globally. For example, according to the International Society of Aesthetic Plastic Surgery, plastic surgery procedures dropped during the pandemic. Approximately 10.9% and around 78% of surgeons experienced temporary practice closure. Furthermore, according to the national health institute, orthopedic surgery was down by about 23% during the first pandemic year. Among which orthopedic surgeries, knee arthroplasty had the utmost influence. It was down by almost 64%, pursued by hip arthroplasty and knee ligament reconstruction by about 41% and 44%, respectively, lessening the need for a tourniquet market. These statistics show that the tourniquet market was negatively impacted by the COVID-19 pandemic globally.

Segment Analysis

Tourniquet systems are expected to dominate the market throughout the forecast period (2022-2029).

The increasing access to specialty care products, pathological products, clinical examination, and diagnosis at a single premise is best possible in hospitals, indicating an exponential segment growth. Hospitals are the major end-user facilities for tourniquets. Moreover, the increasing numeral of sports-related injuries and road casualties raises the number of orthopedic cases, thereby driving the need for hospital-related cases. According to the National Safety Council (NSC), over 55.4 million injuries were experienced in the United States, a 15.7% increase from 2019 to 2020. The Bureau of Labor Statistics (BLS) reports that private industry employers registered over 2.7 million nonfatal workplace injuries and illnesses in 2020. The preventable injuries in the home in 2020 were about 31,800,000 means that one person in 10 in the U.S. encountered a medically consulted injury. Likewise, bicycling accounted for about 426,000 injuries in 2020. According to the National Center for Health Statistics, part of the Centers for Disease Control and Prevention, hospital emergency rooms across the country receive over 145.6 million patients annually.

Old people are more susceptible to orthopedic disorders. According to the World Population Aging globally, there were 727 million persons aged 65 years or over in 2020. Since women live longer than men, they comprise the majority of older persons, especially at advanced ages. This rise in life expectancies and age-related comorbidities results in the growth of geriatric orthopedic surgical procedures. Additionally, the central government offers partial or complete coverage for in-home services in most developed and developing nations. In the U.S., Medicare reimbursements are highly favorable in providing value-based healthcare for improved patient outcomes at a low cost. Thus, from the mentioned data, it is estimated that the hospital end user will dominate the global tourniquet market throughout the forecast period.

Geographical Analysis

The North American region holds the largest global Tourniquet market share.

North American tourniquets market will grow at high CAGR throughout the forecast period (2022-2029). According to the International Society of Aesthetic Plastic Surgery, the U.S. had an immense number of surgeons, with over 7,000 plastic surgeons in 2020, conducted across 3,182,815 non-surgical procedures and approximately 1,485,116 Surgical practices. Again, according to the same survey, the total number of operations executed in Mexico was over 860,718 in 2020. Likewise, from the data obtained by the U.S. Department of transportation`s fatality analysis reporting system, approximately 35,766 fatal vehicle crashes occurred in the U.S. in 2020, inducing roughly 38,824 deaths.

Additionally, there are presently nearly 18,380 orthopedic surgeons in America practicing, indicating that North America maintains a major market share. Another reason North America owns a significant market share is the risen prevalence of obesity. For example, according to the National data from the 2017-2020 National Health and Nutrition Examination Survey, more than 41.9% of adults are obese. Therefore, from about mentioned data, it is predicted that North America will dominate the global Tourniquet Market during the forecast period (2022-2029).

Competitive Landscape

The tourniquet market is moderately competitive due to the presence of key local and global players. Some key players are Zimmer Biomet, Stryker, ATMOS MedizinTechnik GmbH & Co. KG, VBM, DDM, Anetic Aid, HPM, Huifeng Medical, DS MAREF, and Bohua Medical. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2021, ATMOS MedizinTechnik GmbH & Co. KG acquired the tourniquets device portfolio of Ulrich medical.

Zimmer Biomet

Overview:

Zimmer Biomet was in 1927 and has operations in more than 25 countries around the world and more than 100 countries to sell their product with a vast portfolio. Also, it is a leading company focusing on alleviating pain and improving the quality of life for people around the world.

Product Portfolio:

Zimmer Biomet's tourniquet product portfolio has A.T.S. 5000 Tourniquet Systems: The A.T.S. 5000 combines Personalized Pressure Technology with the new customizable user choosing to deliver a personalized experience for patients and healthcare professionals without disrupting workflow.

The global tourniquet market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Number of Orthopedic and Plastic Surgeries
      • 4.1.1.2. Increasing Incidents of Road Accidents
    • 4.1.2. Restraints
      • 4.1.2.1. Tourniquet Injuries
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Tourniquet Instrument
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tourniquet cuffs
    • 7.3.1. Pneumatic Tourniquet Cuffs*
    • 7.3.2. Non-Pneumatic Tourniquet Cuffs

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Upper-Limb Surgery
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Lower-Limb Surgery
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgery Centers
  • 9.4. Orthopedic Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Zimmer Biomet
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Stryker
  • 12.3. ATMOS MedizinTechnik GmbH & Co. KG
  • 12.4. VBM
  • 12.5. DDM
  • 12.6. Anetic Aid
  • 12.7. HPM
  • 12.8. Huifeng Medical
  • 12.9. DS MAREF
  • 12.10. Bohus Medical

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us